대한신장학회

Skip Navigation: Skip to contents

KOR
ENG
전체메뉴보기

간행물 검색

현재 페이지 경로

HOME
간행물
간행물 검색

논문분류	춘계학술대회 초록집
제목	Efficacy and safety of short term cinacalcet for secondary hyperparathyroidism in hemodialysis patients
저자	Phongsak Dandecha,Piyanut Kaewdoungtien
출판정보	2022; 2022(1):
키워드
초록	Objectives: to find the efficacy and safety of cinacalcet for the treatment of SHPT in patients who had failed from vitamin D therapy in Songklanagarind hospital after new KDOQI guidelines and clinical practice Methods: This was an retrospective cohort study in hemodialysis patients who had failed from vitamin D therapy and used cinacalcet at Songklanagarind hospital, from 1st October 2015 to 31st October 2017 and followed up for 6 months. Primary objective was response rate which was defined as serum iPTH level less than 585 pg/dL (< 9 fold upper normal limit for the assay) at 3 and 6 months of treatment and predictors. Secondary objectives was to find adverse events. Results: 70 hemodialysis patients (mean age 60±13 years) were treated with cinacalcet. 48.6% of the patients were female. Baseline iPTH levels were 1,063 (842.5, 1,423.8) pg/dL. Patients responded at 3 and 6 months at 32.3% (21/65) (95%CI 0-43%, P=0.053) and 39.3% (24/61) (95%CI 0-50.7%, P=0.327) respectively. Predictors to response at 3 month were no hyperlipidemia(OR 3.46 (1.03,11.61)) and iPTH level before treatment < 900 pg/mL (OR 3.51 (1.13,10.91)). There was no predictor to response at 6 months. The most common adverse events were hypocalcemia (23%) and nausea (3%) without serious clinicals. Conclusions: Cinacalcet is effective for the treatment of SHPT in the hemodialysis patient after failed to vitamin D even with delayed initiation and with new iPTH level goal of new KDIGO guideline without serious clinical complications.
원문(PDF)	PDF 원문보기

목록

위로가기